Literature DB >> 19875283

Novel pyrazolopyrimidines as highly potent B-Raf inhibitors.

Martin J Di Grandi1, Dan M Berger, Darrin W Hopper, Chunchun Zhang, Minu Dutia, Alejandro L Dunnick, Nancy Torres, Jeremy I Levin, George Diamantidis, Christoph W Zapf, Jonathan D Bloom, YongBo Hu, Dennis Powell, Donald Wojciechowicz, Karen Collins, Eileen Frommer.   

Abstract

A novel series of pyrazolo[1,5-a]pyrimidines bearing a 3-hydroxyphenyl group at C(3) and substituted tropanes at C(7) have been identified as potent B-Raf inhibitors. Exploration of alternative functional groups as a replacement for the C(3) phenol demonstrated indazole to be an effective isostere. Several compounds possessing substituted indazole residues, such as 4e, 4p, and 4r, potently inhibited cell proliferation at submicromolar concentrations in the A375 and WM266 cell lines, and the latter two compounds also exhibited good therapeutic indices in cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875283     DOI: 10.1016/j.bmcl.2009.10.058

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  7-Chloro-5-(chloro-meth-yl)pyrazolo-[1,5-a]pyrimidine-3-carbonitrile.

Authors:  Jingli Xu; Hang Liu; Guixia Li; Chuanmin Qi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-24

2.  18F-labeled pyrazolo[1,5-a]pyrimidine derivatives: synthesis from 2,4-dinitrobenzamide and tosylate precursors and comparative biological evaluation for tumor imaging with positron emission tomography.

Authors:  Jingli Xu; Hang Liu; Guixia Li; Yong He; Rui Ding; Xiao Wang; Man Feng; Shuting Zhang; Yurong Chen; Shilei Li; Mingxia Zhao; Yingruo Li; Chuanmin Qi; Yonghong Dang
Journal:  Molecules       Date:  2012-03-27       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.